Corpus Intelligence IC Memo — LINDSAY MUNICIPAL HOSPITAL AUTHORITY 2026-04-26 09:06 UTC
IC Memo — LINDSAY MUNICIPAL HOSPITAL AUTHORITY
Investment Committee Memorandum | OK | 26 beds | Grade D | EBITDA uplift $1.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LINDSAY MUNICIPAL HOSPITAL AUTHORITY

CCN 370214 | GARVIN, OK | 26 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

LINDSAY MUNICIPAL HOSPITAL AUTHORITY is a 26-bed safety-net/medicaid heavy in GARVIN, OK with $16.5M in net patient revenue and a -2.0% operating margin. The hospital serves a payer mix of 0.9% Medicare, 87.0% Medicaid, and 12.1% commercial.

Thesis: Turnaround. Our ML models identify $1.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.0% to 5.4% (+736bps).

Net Revenue HCRIS$16.5M
Current EBITDA COMPUTED$-323K
Operating Margin COMPUTED-2.0%
Occupancy HCRIS66.6%
Revenue / Bed COMPUTED$634K
Net-to-Gross HCRIS133.0%
Distress Probability ML70.9%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
85
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -2.0% places it above the state median. Among 85 size-comparable peers (13-52 beds), the median margin is -16.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (13-52), prioritizing same-state peers. 85 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LINDSAY MUNICIPAL HOSPITAL AUT (Target)OK26$16.5M-2.0%
STILLWATER MEDICAL CENTEROK52$270.2M-9.9%
OKLAHOMA HEART HOSPITAL SOUTHOK43$148.5M-0.6%
COMMUNITY HOSPITALOK45$143.9M21.7%
OKLAHOMA SPINE HOSPITALOK23$79.0M8.4%
JACKSON COUNTY MEMORIAL HOSPITOK49$75.5M-10.7%
TULSA SPINE HOSPITALOK38$69.5M11.6%
HILLCREST HOSPITAL CLAREMOREOK41$68.5M5.8%
BAILEY MEDICAL CENTEROK33$54.6M13.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$346K+210bp18mo
Cost to Collect4.5%2.5%$330K+200bp12mo
Denial Rate Reduction12.0%6.5%$326K+198bp12mo
A/R Days Reduction5200.0%3800.0%$201K+122bp9mo
Clean Claim Rate88.0%96.0%$11K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$346K
Cost to Collect
$330K
Denial Rate Reduction
$326K
A/R Days Reduction
$201K
Clean Claim Rate
$11K
Total EBITDA Uplift$1.2M
Current EBITDA$-323K
+ RCM Uplift+$1.2M
Pro Forma EBITDA$891K
Current Margin-2.0%
Pro Forma Margin5.4%
WC Released (1x)$632K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-496K$10.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-496K$10.8M0.00x-100.0%
Bull Case9.0x11.0x$-447K$14.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-447K$15.9M0.00x-100.0%
Bear Case11.0x10.0x$-546K$4.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-546K$4.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (87.0%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 70.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 85 hospitals with 13-52 beds
  • Same-state prioritization (n=86)
  • Comp margins: P25=-26.2% / P50=-16.7% / P75=-1.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.